logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Peakman, Mark, Dr
    Director born in February 1959
    Individual (1 offspring)
    Officer
    icon of calendar 2015-01-28 ~ now
    OF - Director → CIF 0
    Dr Mark Peakman
    Born in February 1959
    Individual (1 offspring)
    Person with significant control
    icon of calendar 2016-04-06 ~ now
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
  • 2
    Evanson, Elizabeth Jane, Dr
    Individual (3 offsprings)
    Officer
    icon of calendar 2015-04-01 ~ now
    OF - Secretary → CIF 0
Ceased 1
  • Peakman, Mark, Dr
    Individual (1 offspring)
    Officer
    icon of calendar 2015-01-28 ~ 2015-04-01
    OF - Secretary → CIF 0
parent relation
Company in focus

PEAK THERAPEUTICS LIMITED

Standard Industrial Classification
86220 - Specialists Medical Practice Activities
Brief company account
Property, Plant & Equipment
1,011 GBP2024-01-31
276 GBP2023-01-31
Debtors
50 GBP2024-01-31
12,823 GBP2023-01-31
Cash at bank and in hand
385,866 GBP2024-01-31
340,333 GBP2023-01-31
Current Assets
385,916 GBP2024-01-31
353,156 GBP2023-01-31
Creditors
Amounts falling due within one year
-12,242 GBP2024-01-31
-23,643 GBP2023-01-31
Net Current Assets/Liabilities
373,674 GBP2024-01-31
329,513 GBP2023-01-31
Net Assets/Liabilities
374,685 GBP2024-01-31
329,789 GBP2023-01-31
Equity
Called up share capital
100 GBP2024-01-31
100 GBP2023-01-31
Retained earnings (accumulated losses)
374,585 GBP2024-01-31
329,689 GBP2023-01-31
Equity
374,685 GBP2024-01-31
329,789 GBP2023-01-31
Average Number of Employees
12023-02-01 ~ 2024-01-31
12022-02-01 ~ 2023-01-31
Property, Plant & Equipment - Gross Cost
1,854 GBP2024-01-31
544 GBP2023-01-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
843 GBP2024-01-31
268 GBP2023-01-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
575 GBP2023-02-01 ~ 2024-01-31

  • PEAK THERAPEUTICS LIMITED
    Info
    Registered number 09409822
    icon of address12 Beckwith Road, Herne Hill, London SE24 9LG
    Private Limited Company incorporated on 2015-01-28 (10 years 9 months). The company status is Active.
    The last date of confirmation statement was made at 2025-02-14
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 16 October 2025 and licensed under the Open Government Licence v3.0.